InvestorsHub Logo
Post# of 252528
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: DewDiligence post# 85586

Wednesday, 11/04/2009 3:05:13 AM

Wednesday, November 04, 2009 3:05:13 AM

Post# of 252528
IDIX has initiated a Phase II clinical trial evaluating IDX184+ SoC for 14 days and doses of up to 200mg (Patients will continue on treatment with pegylated interferon and ribavirin for 14 more days):

http://finance.yahoo.com/news/Idenix-Pharmaceuticals-prnews-2318795928.html/print?x=0

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.